Status
Conditions
Treatments
About
This study evaluates the impact of CADx assistance on endoscopists' histologic characterization of diminutive colorectal polyps (≤5 mm) during colonoscopy. The primary objective is to determine whether CADx assistance increases the proportion of endoscopists who meet PIVI-related performance thresholds, thereby supporting implementation of the "resect and discard" and "diagnose and leave" strategies in routine clinical practice.
Full description
This study evaluates the impact of CADx assistance on endoscopists' histologic characterization of diminutive colorectal polyps (≤5 mm) during colonoscopy. The primary objective is to determine whether CADx assistance increases the proportion of endoscopists who meet PIVI-related performance thresholds, thereby supporting implementation of the "resect and discard" and "diagnose and leave" strategies in routine clinical practice.
In this randomized controlled trial, endoscopists will be assigned to one of three arms: no CADx assistance, CADx assistance without prediction probability, or CADx assistance with prediction probability. The CADx system provides NICE-based histology predictions (Type 1 vs Type 2), which endoscopists may use to support optical diagnosis and subsequent management decisions, including surveillance interval recommendations when applicable. Outcomes will compare endoscopist-level pass rates and diagnostic performance metrics relevant to PIVI-based adoption, with histopathology as the reference standard where applicable.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
-Endoscopists without colonoscopy and NBI experience
Primary purpose
Allocation
Interventional model
Masking
363 participants in 3 patient groups
Loading...
Central trial contact
Xiaobo Li
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal